First-order kinetic model of Alzheimer's β-amyloid fibril extension in vitro

Laboratory Investigation

Volumn 74, Issue 2, 1996, Pages 374-383

  Naiki, Hironobu ^a   Nakakuki, Kazuya ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; THIOFLAVINE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DEPOLYMERIZATION; ELECTRON MICROSCOPY; FLUOROMETRY; KINETICS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN POLYMERIZATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; TEMPERATURE; THIAZOLES;

EID: 0030030956     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
2. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, and Glabe C (1992). Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 267:546-554.
3. Cai X-D, Golde TE, and Younkin SG (1993). Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259:514-516.
4. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, and Selkoe DJ (1992). Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-674.
5. Higuchi K, Naiki H, Kitagawa K, Kitado H, Kogishi K, Matsushita T, and Takeda T (1995). Apolipoprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic apoA-II. Lab Invest 72:75-82.
6. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, and Ihara Y (1994). Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13:45-53.
7. Jarrett JT and Lansbury PT Jr (1992). Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31:12345-12352.
8. Jarrett JT, Berger EP, and Lansbury PT Jr (1993a). The carboxy terminus of β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697.
9. Jarrett JT and Lansbury PT Jr (1993b). Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-58.
10. Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG, and Szarek WA (1995). Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer's disease. Nature Med 1:143-148.
11. Kitagawa K, Naiki H, Takeda T, and Higuchi K (1994). Age-associated decreases in the messenger ribonucleic acid level and the rate of synthesis of apolipoprotein A-II in murine senile amyloidosis. Lab Invest 70:565-571.
12. LeVine H III (1993). Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Prot Sci 2:404-410.
13. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature (Lond) 372:92-94.
14. Maury CPJ, Nurmiaho-Lassila EL, and Rossi H (1994). Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Try-187 gelsolin peptides. Lab Invest 70:558-564.
15. Maury CPJ (1995). Molecular pathogenesis of β-amyloidosis in Alzheimer's disease and other cerebral amyloidoses. Lab Invest 72:4-16.
16. Naiki H, Higuchi K, Hosokawa M, and Takeda T (1989). Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflaviine T. Anal Biochem 177:244-249.
17. Naiki H, Higuchi K, Matsushima K, Shimada A, Chen W-H, Hosokawa M, and Takeda T (1990). Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: use of the fluorescent indicator, thioflavine T. Lab Invest 62:768-73.
18. Naiki H, Higuchi K, Nakakuki K, and Takeda T (1991). Kinetic analysis of amyloid fibril polymerization in vitro. Lab Invest 65:104-110.
19. Naiki H, Higuchi K, Shimada A, Takeda T, and Nakakuki K (1993). Genetic analysis of murine senile amyloidosis. Lab Invest 68:332-337.
20. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, and Ball MJ (1993). β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 90:10836-10840.
21. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, and Martins R, Hockey A, Montgomery P, Beyreuther K, and Masters CL (1989). Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320:1446-1452.
22. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, and Schnek D (1992). Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327.
23. 717) mutants. Science 264:1336-1340.
24. Takeda T, Hosokawa M, and Higuchi K (1991). Senescence-accelerated mouse (SAM): A novel murine model of accelerated senescence. J Am Geriatr Soc 39:911-919.
25. Tomski SJ and Murphy RM (1992). Kinetics of aggregation of synthetic β-amyloid peptide. Arch Bichem Biophys 294:630-38.
26. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, and Cerami A (1994). Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766-4770.
27. Wisniewski T, Ghiso J, and Frangione B (1991). Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun 179:1247-1254.
28. Wisniewski T, Castano E, Ghiso J, and Frangione B (1993). Cerebrospinal fluid inhibits Alzheimer β-amyloid fibril formation in vitro. Ann Neurol 34:631-633.
29. Wisniewski T, Castano EM, Golabek A, Vogel T, and Frangione B (1994). Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030-1035.